Matches in SemOpenAlex for { <https://semopenalex.org/work/W3021557401> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W3021557401 endingPage "6" @default.
- W3021557401 startingPage "73" @default.
- W3021557401 abstract "Adenosine deaminase (ADA) is an enzyme of purine metabolism commonly associated with severe combined immunodeficiency disease and believed to modulate bioactivity of insulin. Its contributory role in patients with metabolic syndrome (having features such as obesity, insulin resistance, fasting hyperglycaemia, lipid abnormalities and hypertension) in South Eastern Nigeria was studied. Body mass index (BMI), fasting blood glucose (FBG), Glycated haemoglobin (GHbA1c), total cholesterol, HDL-cholesterol, LDL-cholesterol (usually impaired in metabolic syndrome) and total serum ADA activity were measured in different groups of patients with metabolic syndrome (test subjects) and apparently healthy subjects (controls). The test subjects comprised six subgroups made up of the following; obese diabetic (N=25), obese non-diabetic (N=25), Non-obese diabetic (N=25), patients with hypercholesterolaemia (N=25), LDL-cholesterolaemia (N=25) and HDL-cholesterolaemia (N=25). The results showed that the mean values of all the parameters studied (BMI, FBG, GHbA1c, total cholesterol, HDL-cholesterol and LDL-cholesterol) were higher in the test subjects than their controls. BMI did not correlate significantly with FBG, GHbA1c, and ADA in the test and control subjects respectively. The mean serum ADA activity in the test subjects of obese diabetic, obese non-diabetic and non-obese diabetic subjects was higher than in controls (p< 0.001). ADA activity was also higher in the test subjects of hypercholesterolaemia, HDL-cholesterolaemia and LDL-cholesterolaemia than in control (p< 0.001). ADA activity also correlated positively with hypercholesterolemia (r = 0.640; p<0.001), HDL-cholesterolaemia (r = 0.646; p<0.001) and LDL-cholesterolaemia (r = 0.932; p<0.001), with the highest correlation in the LDL-cholesterolaemia. In conclusion, ADA activity is increased significantly in all parameters of metabolic syndrome studied and showed a significant correlation with all the three groups of dyslipidaemic subjects studied. ADA could therefore be used in daily routine laboratory assessment of most metabolic diseases especially in obese and diabetic patients." @default.
- W3021557401 created "2020-05-13" @default.
- W3021557401 creator A5033719723 @default.
- W3021557401 creator A5066894512 @default.
- W3021557401 creator A5088776004 @default.
- W3021557401 date "2013-08-10" @default.
- W3021557401 modified "2023-09-23" @default.
- W3021557401 title "Contributory role of adenosine deaminase in metabolic syndrome." @default.
- W3021557401 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23955411" @default.
- W3021557401 hasPublicationYear "2013" @default.
- W3021557401 type Work @default.
- W3021557401 sameAs 3021557401 @default.
- W3021557401 citedByCount "3" @default.
- W3021557401 countsByYear W30215574012018 @default.
- W3021557401 countsByYear W30215574012021 @default.
- W3021557401 crossrefType "journal-article" @default.
- W3021557401 hasAuthorship W3021557401A5033719723 @default.
- W3021557401 hasAuthorship W3021557401A5066894512 @default.
- W3021557401 hasAuthorship W3021557401A5088776004 @default.
- W3021557401 hasConcept C126322002 @default.
- W3021557401 hasConcept C134018914 @default.
- W3021557401 hasConcept C2776991684 @default.
- W3021557401 hasConcept C2777391703 @default.
- W3021557401 hasConcept C2778163477 @default.
- W3021557401 hasConcept C2780221984 @default.
- W3021557401 hasConcept C2780578515 @default.
- W3021557401 hasConcept C34628245 @default.
- W3021557401 hasConcept C511355011 @default.
- W3021557401 hasConcept C555293320 @default.
- W3021557401 hasConcept C71924100 @default.
- W3021557401 hasConceptScore W3021557401C126322002 @default.
- W3021557401 hasConceptScore W3021557401C134018914 @default.
- W3021557401 hasConceptScore W3021557401C2776991684 @default.
- W3021557401 hasConceptScore W3021557401C2777391703 @default.
- W3021557401 hasConceptScore W3021557401C2778163477 @default.
- W3021557401 hasConceptScore W3021557401C2780221984 @default.
- W3021557401 hasConceptScore W3021557401C2780578515 @default.
- W3021557401 hasConceptScore W3021557401C34628245 @default.
- W3021557401 hasConceptScore W3021557401C511355011 @default.
- W3021557401 hasConceptScore W3021557401C555293320 @default.
- W3021557401 hasConceptScore W3021557401C71924100 @default.
- W3021557401 hasIssue "1" @default.
- W3021557401 hasLocation W30215574011 @default.
- W3021557401 hasOpenAccess W3021557401 @default.
- W3021557401 hasPrimaryLocation W30215574011 @default.
- W3021557401 hasRelatedWork W1979252938 @default.
- W3021557401 hasRelatedWork W1992214056 @default.
- W3021557401 hasRelatedWork W1998434356 @default.
- W3021557401 hasRelatedWork W2151350502 @default.
- W3021557401 hasRelatedWork W2169206971 @default.
- W3021557401 hasRelatedWork W2171538978 @default.
- W3021557401 hasRelatedWork W2378290744 @default.
- W3021557401 hasRelatedWork W2391899759 @default.
- W3021557401 hasRelatedWork W2584731720 @default.
- W3021557401 hasRelatedWork W3032853368 @default.
- W3021557401 hasVolume "28" @default.
- W3021557401 isParatext "false" @default.
- W3021557401 isRetracted "false" @default.
- W3021557401 magId "3021557401" @default.
- W3021557401 workType "article" @default.